Li Calzi Sergio, Periyasamy Sumudra, Li Da Pei, Sánchez Edwin R
Department of Pharmacology, Medical College of Ohio, 3035 Arlington Avenue, Toledo, OH 43614-5804, USA.
J Steroid Biochem Mol Biol. 2002 Jan;80(1):35-47. doi: 10.1016/s0960-0760(01)00180-7.
Transition metal oxyanions, such as molybdate, tungstate and vandadate, have been shown to prevent in vitro hormone-induced activation of the glucocorticoid receptor (GR) by blocking dissociation of the GR/heat shock protein heterocomplex. In this work, we report a novel effect of vanadate: in vivo potentiation of GR-mediated gene expression. In cells stably-transfected with complex (mouse mammary tumor virus (MMTV)) or minimal GR-regulated CAT reporters, treatment with 500muM vanadate caused CAT gene expression to dramatically increase, even at saturating concentrations of dexamethasone; while no such effect was seen in response to RU486 antagonist. Similar treatment with molybdate had no effect on GR activity, suggesting that the response to vanadate was not a general property of transition metal oxyanions. Treatment with vanadate after hormone-induced nuclear translocation of the GR also caused potentiation, demonstrating that vanadate was acting on a post-transformation event, perhaps by affecting the transactivation function of DNA-bound GR. Paradoxically, vanadate caused an apparent but temporary "loss" of GR protein immediately after treatment (as measured by loss of reactivity to BuGR2 antibody and of hormone-binding capacity) that returned to normal at approximately 8h post-treatment, suggesting that potentiation of GR transactivation function (as measured by our CAT assays) was probably occurring during the later stages (8-24h) of this assay. However, gel shift analyses revealed that vanadate could induce binding of the hormone-free GR to glucocorticoid response element (GRE)-containing oligonucleotides immediately after treatment. Thus, the rapid vanadate-induced "loss" of GR was not due to degradation of GR protein. Yet, vanadate in the absence of hormone had no effect on CAT reporter expression, demonstrating that this form of the GR still requires agonist for its enhanced transcriptional activity. As an indication of the potential mechanism of vanadate action, vanadate was found to dramatically stimulate the mitogen-activated protein kinases, ERK-1 and ERK-2. In addition, vanadate potentiation of GR reporter gene expression was completely blocked by the tyrosine kinase inhibitor herbimycin A. Taken as a whole, our results suggest that vanadate can have dramatic and complex effects on GR structure and function, resulting in hormone-free activation of GR DNA-binding function, as well as alterations to the BuGR2 epitope and hormone-binding domains--while at the same time stimulating tyrosine phosphorylation pathways controlling GR-mediated gene transcription.
过渡金属含氧阴离子,如钼酸盐、钨酸盐和钒酸盐,已被证明可通过阻断糖皮质激素受体(GR)/热休克蛋白异源复合物的解离来阻止体外激素诱导的GR激活。在本研究中,我们报道了钒酸盐的一种新作用:在体内增强GR介导的基因表达。在用复合(小鼠乳腺肿瘤病毒(MMTV))或最小GR调节的CAT报告基因稳定转染的细胞中,用500μM钒酸盐处理可使CAT基因表达显著增加,即使在地塞米松饱和浓度下也是如此;而对RU486拮抗剂无此反应。用钼酸盐进行类似处理对GR活性无影响,表明对钒酸盐的反应不是过渡金属含氧阴离子的一般特性。在激素诱导GR核转位后用钒酸盐处理也导致增强作用,表明钒酸盐作用于转化后事件,可能是通过影响与DNA结合的GR的反式激活功能。矛盾的是,钒酸盐处理后立即导致GR蛋白明显但暂时的“丢失”(通过对BuGR2抗体的反应性丧失和激素结合能力来衡量),在处理后约8小时恢复正常,这表明GR反式激活功能的增强(通过我们的CAT测定法衡量)可能发生在该测定的后期(8 - 24小时)。然而,凝胶迁移分析显示,钒酸盐处理后可立即诱导无激素的GR与含糖皮质激素反应元件(GRE)的寡核苷酸结合。因此,钒酸盐快速诱导的GR“丢失”不是由于GR蛋白降解。然而,在无激素情况下钒酸盐对CAT报告基因表达无影响,表明这种形式的GR仍然需要激动剂来增强其转录活性。作为钒酸盐作用潜在机制的一个指标,发现钒酸盐可显著刺激丝裂原活化蛋白激酶ERK - 1和ERK - 2。此外,GR报告基因表达的钒酸盐增强作用被酪氨酸激酶抑制剂赫曲霉素A完全阻断。总体而言,我们的结果表明,钒酸盐可对GR结构和功能产生显著而复杂的影响,导致无激素激活GR的DNA结合功能,以及改变BuGR2表位和激素结合结构域,同时刺激控制GR介导基因转录的酪氨酸磷酸化途径。